Diabetes affects 382 million people globally and 10 per cent (38m) of those people live in the MEA region. We offer solutions for type 1, type 2 and gestational diabetes. We manufacture different insulin formulations of recombinant human insulin and we also offer continuous glucose monitoring systems.

You can find an A-Z list of our Julphar Diabetes Solutions products below. Unfortunately, we cannot provide comprehensive information about our medicines on this website, in compliance with regulations.

To find out more about Julphar Diabetes Solutions please go to our sister website www.julphardiabetes.net